Epicatechin attenuates the stemness of liver cancer stem cells and tumorigenesis through DNA methylation-mediated inactivation of GINS1/HRAS
Abstract Background The limited therapeutic options for hepatocellular carcinoma (HCC) are primarily attributed to the presence of liver cancer stem cells (LCSCs). Epicatechin (EC) is known to exert therapeutic effects on cancer. Go-ichi-ni-san complex subunit 1 (GINS1) is an oncogene associated wit...
Saved in:
| Main Authors: | Xingbao Fang, Yan Cai, Xiongbing Peng, Zhaojun Li, Meifang Huang, Yuehong Li, Peiwan Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06790-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms of HRAS regulation of liver hepatocellular carcinoma for prognosis prediction
by: Xingbao Fang, et al.
Published: (2025-04-01) -
Distinct association of HRAS and KRAS with Mn2+ ion illustrated by paramagnetic NMR
by: Jia-Liang Chen, et al.
Published: (2025-02-01) -
(−)‐Epicatechin Rescues Memory Deficits by Activation of Autophagy in a Mouse Model of Tauopathies
by: Yanqing Wu, et al.
Published: (2025-04-01) -
Positive Effects of (+)-Epicatechin on Traumatic Spinal Cord Injury Recovery
by: Cristian Gonzalez-Ruiz, et al.
Published: (2025-06-01) -
Paeoniflorin alleviates high glucose-induced endothelial cell apoptosis in diabetes mellitus by inhibiting HRAS-activated RAS pathway
by: Wenting Yu, et al.
Published: (2024-11-01)